logo
Accidental find in planetarium show could shift scientists' understanding of our solar system

Accidental find in planetarium show could shift scientists' understanding of our solar system

CNNa day ago

CNN —
An accidental discovery might change how we think about one of the most mysterious structures in our solar system.
The Oort Cloud, a large expanse of icy bodies revolving around the sun at a distance 1,000 times greater than the orbit of Neptune, is widely thought to be spherical — although it has never been directly observed.
But during the preproduction of a show titled 'Encounters in the Milky Way,' which debuted Monday at the Hayden Planetarium in New York City, a projection on the planetarium's dome revealed something strange within the Oort Cloud: a spiral.
The curators were testing out a scene in September that includes a detailed view of Earth's celestial neighborhood — from the sun to the solar system's outer edges — and were surprised when they saw the structure, which looked coincidentally similar to a spiral galaxy such as our own.
'We hit play on the scene, and immediately we saw it. It was just there,' recalled Jackie Faherty, an astrophysicist at the American Museum of Natural History and the curator of the show. 'I was confused and thought that was super weird. I didn't know if it was an artifact, I didn't know if it was real.'
To investigate, Faherty got in touch with David Nesvorny, an institute scientist with the Southwest Research Institute in Boulder, Colorado, and the Oort Cloud expert who had provided scientific data for the scene.
'We didn't create it — David did,' Faherty said. 'This is David's simulation, and it's grounded in physics. It has a totally good physical explanation for why it should be there.'
At first, Nesvorny suspected artifacts — abnormalities or distortions in the data visualization — but once he looked at his data, he confirmed the presence of the spiral and eventually published a scientific paper about the discovery in April in The Astrophysical Journal. 'Weird way to discover things,' he said. 'I should know my data better, after years of working with it.'
Crazy, long orbits
The existence of the Oort Cloud was first proposed in 1950 by Dutch astronomer Jan Oort, who imagined it as a shell of icy bodies swirling around the sun from up to 1.5 light-years away. The cloud is the most distant region in our solar system, stretching as much as halfway to the next star, according to NASA.
It's composed of leftovers from the making of our solar system, which were scattered in every direction by the planets after they formed. That means many of the icy bodies in the Oort Cloud don't share the same orbital plane as the solar system itself but travel at various inclinations, which is why the Oort Cloud is pictured as a sphere. If one of those icy bodies gets flung inward toward the sun, the heat starts vaporizing some of the material in the body, creating a tail — and what we call a comet.
'Every now and again, some of these icy bodies come into the inner solar system, and we can see the orbit that they're on,' Faherty said. 'And they're on these really crazy, long orbits. It can take them millions of years to go around the sun. And when they come in, they help us understand how far away they may have come from.'
The problem with trying to imagine what the Oort Cloud looks like is that scientists have never seen it, even though we are technically surrounded by it. That's because the bodies that make it up are small — fewer than 60 miles (97 kilometers) in diameter — and even though they potentially number in the trillions, they are far away, making observations with telescopes difficult.
The spiral was hiding in Nesvorny's data because he had never thought of visualizing it three-dimensionally. 'I never looked at it in Cartesian coordinates — I didn't have a good reason to do so,' he said. 'But once you do that, it's obvious. It's there.'
The galactic tide
To confirm the findings, Nesvorny used one of the most powerful computers in the world, NASA's Pleiades Supercomputer, to run simulations that took weeks to complete.
'I thought, maybe just this particular simulation (I gave the planetarium) is showing it, and all the other simulations with other stellar encounters, other parameters, will not show it, in which case it wouldn't be so interesting,' he said. 'But all the simulations, all the models I have, show the spiral.'
The reason it's there, he said, is that objects in the Oort Cloud are far away enough from the sun's gravity that they also start being affected by the galactic tide — the gravitational field of our galaxy, exerted by the stars and the dark matter in it. This field is acting on the small bodies and comets in the Oort Cloud by twisting their orbital planes to create a spiral.
The spiral, Nesvorny added, is in the inner part of the Oort Cloud, the closest to us, and he still believes that the outer portion is spherical or shell-shaped.
The problem of observing the Oort Cloud remains, even though the Vera C. Rubin Observatory, a powerful telescope that recently came online in Chile, could offer a hand by discovering and observing individual icy bodies in the cloud. However, according to Nesvorny, the telescope will likely discover dozens of these bodies — not the hundreds that would be required to produce a meaningful visualization of the spiral.
The spiral theory helps to illuminate the dynamics of our solar system, according to Faherty. 'If you're going to come up with a theory of how solar systems evolve, you should take into account the kind of shapes you might have in their structure,' she said. 'Maybe comets helped deliver water to Earth. Maybe the building blocks of life could be out there in the Oort Cloud, so if you want to talk about the potential building blocks of life that surround our solar system, you need to understand its shape.'
It's a 'dream,' she added, to be able to present science so recent in a show aimed at the general public. 'I truly believe that the planetarium, the dome itself, is a research tool,' Faherty said. 'I like to say that this is science that hasn't had time to reach your textbook yet.'
Viewing what's not visible
The spiral finding is a wonderful example of just how much we can learn through visualizing the universe in new ways, said Malena Rice, an assistant professor of astronomy at Yale University who did not participate in the study.
'This result reshapes our mental image of our home solar system, while also providing a new sense for what extrasolar systems' Oort clouds may look like,' Rice added. 'It unites our models of the solar system with what we know about the broader galaxy, placing it into context as a dynamic system. We are not static, and we are not isolated — our solar system is shaped by its broader ecosystem, and the Oort spiral exemplifies that.'
While the paper is interesting, it is almost entirely theoretical, as it is based on numerical simulations of the interactions between the sun's gravity and the gravitational pull of the rest of the Milky Way galaxy's motion, said Edward Gomez, an astrophysicist and honorary lecturer at Cardiff University in the UK. He also was not involved with the study.
'Long period comets enter the inner solar system at a range of angles, which the authors try to model using their spiral arm idea,' Gomez said in an email. 'What they are proposing could be true, but it could also be modelled by other shapes of the Oort cloud or physical processes. How to test this is their major issue, because only a handful of potential Oort cloud objects are known about.'
Confirming the findings will be a challenge, noted Simon Portegies Zwart, a professor of numerical star dynamics at Leiden University in the Netherlands who was not part of the team behind the research. 'It is interesting that they found the spiral, (but) it seems unlikely that we are going to witness (it) in the foreseeable future,' he said.
With luck, he added, the Vera Rubin observatory will detect a few hundred inner Oort Cloud objects, but the spiral would only be visible if many more are found: 'It therefore seems unlikely to be a clearly detectable structure.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bats Have Cancer-Fighting ‘Superpowers'—Here's What That Means for Humans
Bats Have Cancer-Fighting ‘Superpowers'—Here's What That Means for Humans

Gizmodo

time22 minutes ago

  • Gizmodo

Bats Have Cancer-Fighting ‘Superpowers'—Here's What That Means for Humans

When you think of longevity in animals, chances are that the Greenland shark will immediately come up. After all, researchers estimate that the enigmatic animal can live for at least 250 years. It turns out, however, that bats also hold their own when it comes to lifespan, with some species living up to 25 years—equivalent to 180 human years—and they tend to do it cancer-free. Researchers from the University of Rochester (UR) have investigated anti-cancer 'superpowers,' as described in a UR statement, in four bat species: the little brown bat, the big brown bat, the cave nectar bat, and the Jamaican fruit bat. The results of their investigation could have important implications for treating cancer in humans. 'Longer lifespans with more cell divisions, and longer exposure to exo- [external] and endogenous [internal] stressors increase cancer incidence,' the researchers wrote in a study published last month in the journal Nature Communications. 'However, despite their exceptional lifespans, few to no tumors have been reported in long-lived wild and captive populations of bats.' Led by biologists Vera Gorbunova and Andrei Seluanov from the UR Department of Biology and Wilmot Cancer Institute, the team identified a number of biological defenses that help bats avoid the disease. For example, bats have a tumor-suppressor gene, called p53. Specifically, little brown bats carry two copies of the gene, and have high p53 activity, which can get rid of cancer cells during apoptosis, a biological process that eliminates unwanted cells. 'We hypothesize that some bat species have evolved enhanced p53 activity as an additional anti-cancer strategy, similar to elephants,' the researchers explained. Too much p53, though, runs the risk of killing too many cells. Clearly, bats are able to find the right apoptosis balance. Humans also have p53, but mutations in the gene—which disrupt its anti-cancer properties—exist in around 50% of human cancers. The researchers also analyzed the enzyme telomerase. In bats, the telomerase expression allows bat cells to multiply endlessly. That means they don't undergo replicative senescence: a feature that restricts cell proliferation to a certain number of divisions. Since, according to the study, senescence 'promotes age-related inflammation contributing to the aging process,' bats' lack thereof would seem to promote longevity. And while indefinite cell proliferation might sound like the perfect cancer hotbed, bats' high p53 activity can kill off any cancer cells. Furthermore, 'bats have unique immune systems which allows them to survive a wide range of deadly viruses, and many unique immune adaptations have been described in bats,' the researchers wrote. 'Most knowledge of the bat immune systems comes from studies of bat tolerance to viral infections deadly to humans. However, these or similar immune adaptations may also recognize and eliminate tumors,' as well as 'temper inflammation, which may have an anticancer effect.' Cells have to go through several steps, or 'oncogenic hits,' to become harmful cancerous cells. Surprisingly, the researchers also found that it only takes two hits for normal bat cells to become malignant, meaning bats aren't naturally resistant to cancer—they just have 'robust tumor-suppressor mechanisms,' as described in the statement. The team's findings carry important implications for treating cancer. Specifically, the study confirms that increased p53 activity—which is already targeted by some anti-cancer drugs—can eliminate or slow cancer growth. More broadly, their research is yet another example of scientists turning to nature for solutions to human challenges on all scales. Though the study focuses on bats, the ultimate aim is, always, finding a cure for cancer in humans.

IRONMAN: Can PSA Guide Metastatic Prostate Cancer Care?
IRONMAN: Can PSA Guide Metastatic Prostate Cancer Care?

Medscape

time32 minutes ago

  • Medscape

IRONMAN: Can PSA Guide Metastatic Prostate Cancer Care?

CHICAGO — Prostate-specific antigen (PSA) levels could help guide treatment decisions for patients with metastatic hormone-sensitive prostate cancer, according to real-world findings from the IRONMAN study. Specifically, an undetectable PSA nadir — defined as PSA level < 0.2 ng/mL — predicted a good prognosis and a PSA level ≥ 0.2 ng/mL predicted poor prognosis among patients receiving androgen deprivation therapy (ADT) or androgen receptor pathway inhibitor (ARPI) therapy for 6-12 months, according to Michael Ong, MD, who presented the findings at the 2025 American Society of Clinical Oncology annual meeting. In other words, this real-world study found that absolute PSA at 6 and 12 months is prognostic in this patient population, said Ong, a medical oncologist at Ottawa Hospital Research Institute, Canada. Patients with a poor prognosis could then be considered for clinical trials offering therapy escalation, whereas those with a better prognosis — particularly those with PSA < 0.1 ng/mL — could be considered for de-escalation, said Ong. Ong explained that prior phase 3 studies have demonstrated that PSA > 0.2 ng/mL is associated with poor prognosis in patients receiving ADT and ARPI. However, data in real-world settings remain limited. Some patients with rapid PSA decline never progress, whereas others develop early resistance despite intensive therapy, he explained. The IRONMAN study set out to answer two main questions: When should PSA cutoffs be interpreted for prognostic significance? And how may PSA cutoffs differ in real-world patients? To this end, Ong and his colleagues included 1219 patients from the prospective IRONMAN cohort with metastatic hormone-sensitive prostate cancer who had received ADT and ARPI therapy, with or without docetaxel, and had PSA data available. PSA was stratified into three groups: ≥ 0.2 ng/mL, 0.10-0.19 ng/mL, and < 0.10 ng/mL. The research team constructed a 12-month landmark population to assess conditional overall survival (OS) and progression-free survival (PFS) at 6 and 12 months across each PSA level. The 12-month analysis was the primary study outcome. Patients were a median age of 70 years, 58% had Gleason score of 8-10, and 75% had de novo metastatic disease. Overall, most (74%) were White and just over half were enrolled from centers outside US or Canada. ARPI agents included abiraterone acetate (44%), apalutamide (21%), enzalutamide (22%), or darolutamide (13%), and 12% of patients received docetaxel in addition to doublet therapy with ADT plus ARPI. PSA levels shifted across the two time points. At 6 months, 52% of patients had a PSA < 0.2 ng/mL, whereas 48% had a PSA level ≥ 0.2 ng/mL. At 12 months, 68% had PSA levels < 0.2 ng/mL and 32% had levels ≥ 0.2 ng/mL. Both the 6- and 12-month landmark analyses showed that PSA ≥ 0.2 ng/mL was associated with worse conditional OS and PFS compared with PSA < 0.2 ng/mL. Ong broke down conditional OS and PFS at 12 months — the primary study outcome —by absolute PSA levels. Absolute PSA 3-year overall survival 3-year progression-free survival OS mortality risk (adjusted hazard ratio) ≥ 0.2 ng/mL 45% 41% 4.85 (3.36-7.01) 0.10-0.19 ng/mL 79% 62% 1.34 (0.82-2.20) < 0.1 ng/mL 84% 80% Reference After adjustment for confounders, PSA ≥ 0.2 ng/mL was associated with an almost fivefold higher risk for death at 12 months (adjusted hazard ratio, 4.85). Ong noted that PSA was prognostic of overall survival regardless of ARPI class or whether patients received doublet or triplet therapy with docetaxel. Invited discussant Rahul Aggarwal, MD, agreed that a PSA nadir between 6 and 12 months 'is strongly prognostic for progression-free and overall survival.' However, Aggarwal cautioned, although 'it is tempting to use PSA nadir to guide treatment decisions in clinical practice,' the approach has not been validated. Plus, other factors and biomarkers may play a role in treatment decisions and help optimize outcomes, including quality of life, treatment and financial toxicity, and the role of the tumor suppressor gene PTEN , added Aggarwal, of the University of California, San Francisco. 'We await randomized trial data to know, in fact, whether we should use this to guide treatment decision-making,' said Aggarwal. Such trials are underway. Ong is co-chair of a phase 3 study assessing survival after treatment escalation for patients with PSA ≥ 0.2 ng/mL after 6-12 months of ADT and ARPI therapy. Another phase 3 study will assess treatment de-escalation in those with PSA ≤ 0.2 ng/mL at 6-12 months after treatment initiation. This study's principal funder was the Movember Foundation; the Prostate Cancer Clinical Trials Consortium was a trial sponsor, plus Amgen, Astellas, AstraZeneca, Bayer, Janssen, Merck, Novartis and Sanofi provided funding support. Ong disclosed relationships with AstraZeneca, Bayer, Bristol-Myers Squibb, EMD Serono, Janssen, Merck, Novartis/AAA, Pfizer, Sanofi, and Ipsen. Aggarwal disclosed relationships with Alessa Therapeutics, Amgen, AstraZeneca, Bayer, BioXcel Therapeutics, Boxer Capital, Curio Science, and others.

House bipartisan bill directs NSA to create 'AI security playbook' amid Chinese tech race
House bipartisan bill directs NSA to create 'AI security playbook' amid Chinese tech race

Fox News

time36 minutes ago

  • Fox News

House bipartisan bill directs NSA to create 'AI security playbook' amid Chinese tech race

FIRST ON FOX – Rep. Darin LaHood, R-Ind., is introducing a new bill Thursday imploring the National Security Administration (NSA) to develop an "AI security playbook" to stay ahead of threats from China and other foreign adversaries. The bill, dubbed the "Advanced AI Security Readiness Act," directs the NSA's Artificial Intelligence Security Center to develop an "AI Security Playbook to address vulnerabilities, threat detection, cyber and physical security strategies, and contingency plans for highly sensitive AI systems." It is co-sponsored by House Select Committee on China Chairman Rep. John Moolenaar, R-Mich., Ranking Member Rep. Raja Krishnamoorthi, D-Ill., and Rep. Josh Gottheimer, D-N.J. LaHood, who sits on the House Intelligence Committee and the House Select Committee on China, told Fox News Digital that the legislative proposal, if passed, would be the first time Congress codifies a "multi-prong approach to ensure that the U.S. remains ahead in the advanced technology race against the CCP." He said the bill will improve export control mechanisms – including for chips and high capacity chip manufacturing – protect covered AI technologies with a focus on cybersecurity, and limit outbound investment to firms directly tied to the Chinese Community Party or China's People's Liberation Army. "We start with the premise that China has a plan to replace the United States. And I don't say that to scare people or my constituents, but they have a plan to replace the United States, and they're working on it every single day. And that entails stealing data and infiltrating our systems," LaHood told Fox News Digital. "AI is the next frontier on that. We lead the world in technology. We lead the world when it comes to AI. But what this bill will do will again make sure that things are done the right way and the correct way, and that we're protecting our assets and promoting the current technology that we have in our country." LaHood pointed to evidence uncovered by the committee that he said shows the CCP's DeepSeek used illegal distillation techniques to steal insights from U.S. AI models to accelerate their own technology development. He also pointed to how China allegedly smuggled AI chips through Singapore intermediaries to circumvent U.S. export controls on the technology. "As we look at, 'How do we win the strategic competition?' I think most experts would say we're ahead in AI right now against China, but not by much. It is a short lead," LaHood told Fox News Digital. He said he is confident the bill will put the U.S. "in the best position to protect our assets here and make sure that we're not shipping things that shouldn't go to AI that allow them to win the AI race in China." "Whoever wins this race in the future, it's going to be critical to future warfare capabilities, to, obviously, cybersecurity," LaHood continued. "And then, whoever wins the AI competition is going to yield really unwavering economic influence in the future. And so we're aggressive in this bill in terms of targeting those areas where we need to protect our AI and our companies here in the United States, both on the commercial side and on the government side, to put us in the best position possible." The legislative proposal calls on the NSA to develop a playbook that identifies vulnerabilities in AI data centers and developers producing sensitive AI technologies with an emphasis on unique "threat vectors" that do not typically arise, or are less severe, in the context of conventional information technology systems." The bill says the NSA must develop "core insights" in how advanced AI systems are being trained to identify potential interferences and must develop strategies to "detect, prevent and respond to cyber threats by threat actors targeting covered AI technologies." The bill calls on the NSA to "identify levels of security, if any, that would require substantial involvement" by the U.S. government "in the development or oversight of highly advanced AI systems." It cites a "hypothetical initiative to build covered AI technology systems in a highly secure government environment" with certain protocols in place, such as personnel vetting and security clearance processes, to mitigate "insider threats." Though not directly related, the legislation is being introduced a week after FBI Director Kash Patel sounded the alarm on how the CCP continues to deploy operatives and researchers to "infiltrate" U.S. institutions. Patel laid out the risk in announcing that two Chinese nationals were charged with smuggling a potential bioweapon into the U.S. LaHood said that case further highlights "the level of penetration and sophistication that the CCP will engage in," but he added that his bill focuses on putting a "protective layer" on U.S. AI tech and "restricting outbound investment to China." He pointed to how the CCP also has bought up farmland around strategic U.S. national security locations, particularly in Montana, North Dakota and South Dakota. "If everything was an even playing field, and we were all abiding by the same rules and standards and ethical guidelines, I have no doubt the U.S. would win [the AI race], but China has a tendency and a history of playing by a different set of rules and standards," LaHood said. "They cheat, they steal, they take our intellectual property. Not just my opinion, that's been factually laid out, you know, in many different instances. And that's the reason why we need to have a bill like this." The bill comes as the Trump administration has been pushing to bolster artificial intelligence infrastructure in the United States, and major tech companies, including Amazon, Nvidia, Meta, OpenAI, Oracle and others, have made major investments in constructing AI-focused data centers and enhancing U.S. cloud computing. Last week, Amazon announced a $20 billion investment in constructing AI data centers in rural Pennsylvania. It followed a similar $10 billion investment in North Carolina. In late May, the NSA's Artificial Intelligence Security Center released "joint guidance" on the "risks and best practices in AI data security." The recommendations include implementing methods to secure the data used in AI-based systems, "such as employing digital signatures to authenticate trusted revisions, tracking data provenance, and leveraging trusted infrastructure." The center said its guidance is "critically relevant for organizations – especially system owners and administrators within the Department of Defense, National Security Systems, and the Defense Industrial Base – that already use AI systems in their day-to-day operations and those that are seeking to integrate AI into their infrastructure."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store